Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
OBJECTIVE: Several co-infections have been shown to impact the progression of HIV-1 infection. We sought to determine if treatment of helminth co-infection in HIV-1-infected adults impacted markers of HIV-1 disease progression. DESIGN: To date, there have been no randomized trials to examine the eff...
Main Authors: | Walson, J, Otieno, P, Mbuchi, M, Richardson, B, Lohman-Payne, B, Macharia, S, Overbaugh, J, Berkley, J, Sanders, E, Chung, M, John-Stewart, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double‐blind, placebo‐controlled trial in Vietnam
by: Flohr, C, et al.
Published: (2009) -
Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam.
by: Flohr, C, et al.
Published: (2010) -
Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
by: Morice, A, et al.
Published: (2017) -
Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis
by: Palmeirim, MS, et al.
Published: (2018) -
Novel pharmaceutical salts of albendazole
by: Bolla, Geetha, et al.
Published: (2018)